Skip to main content
Menu
US

AlphaLISA Human IL-17F Detection Kit, 500 Assay Points

The AlphaLISA™ Human IL-17F Detection Kit is designed for detection and quantitation of human interleukin 17F in cell culture media or serum using a homogeneous (no-wash steps, no separation steps) assay.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Feature Specification
Application Protein Quantification
Dynamic Range 16 - 300,000 pg/mL  
Limit of Detection 16 pg/mL  
Limit of Quantification 54 pg/mL  
Sample Volume 5 µL

The AlphaLISA™ Human IL-17F Detection Kit is designed for detection and quantitation of human interleukin 17F in cell culture media or serum using a homogeneous (no-wash steps, no separation steps) assay.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Product Variants
Unit Size: 100 Assay Points
Part #:
AL391HV
List Price
USD 971.37
Unit Size: 500 Assay Points
Part #:
AL391C
List Price
USD 2,917.00
Unit Size: 5,000 Assay Points
Part #:
AL391F
List Price
USD 29,270.00

Overview

Formats:

  • Our 100 assay point kit allows you to run 100 wells in 96-well format, using a 100 µL reaction volume (10 µL of sample).
  • Our 500 assay point kit allows you to run 500 wells in 96-well or 384-well format, using a 50 µL reaction volume (5 µL of sample).
  • Our 5,000 assay point kit allows you to run 5,000 wells in 96-well or 384-well format, using a 50 µL reaction volume (5 µL of sample).

Features:

  • No-wash steps, no separation steps
  • ELISA alternative technology
  • Sensitive detection
  • Broad sample compatibility
  • Small sample volume
  • Results in less than 3 hours
  • Half the time of an ELISA assay

IL17F, also known as human interleukin 17, is a pro-inflammatory cytokine produced by T-helper cells. This cytokine has been found to inhibit the angiogenesis and endothelial cells and induce endothelial cells to produce other cytokines. Levels of this cytokine play an important role in asthma and chronic inflammatory disease such as psoriasis, multiple sclerosis, and rheumatoid arthritis. The present kit is designed to detect IL17F in serum, plasma, cell culture supernatants, and cell lysates.

AlphaLISA technology allows the detection of molecules of interest in a no-wash, highly sensitive, quantitative assay. In an AlphaLISA assay, a biotinylated anti-analyte antibody binds to the Streptavidin-coated Donor beads while another anti-analyte antibody is conjugated to AlphaLISA Acceptor beads. In the presence of the analyte, the beads come into close proximity. The excitation of the Donor beads causes the release of singlet oxygen molecules that triggers a cascade of energy transfer in the Acceptor beads, resulting in a sharp peak of light emission at 615 nm.

Specifications

Application
Protein Quantification
Automation Compatible
Yes
Brand
AlphaLISA
Detection Modality
Alpha
Dynamic Range
16 - 300,000 pg/mL  
Host Species
Human
Limit of Detection
16 pg/mL  
Limit of Quantification
54 pg/mL  
Product Group
Kit
Sample Volume
5 µL
Shipping Conditions
Shipped in Blue Ice
Target
IL17F
Target Class
Cytokines
Target Species
Human
Technology
Alpha
Therapeutic Area
Inflammation
Unit Size
500 Assay Points

Image gallery

Video gallery

Resources

Are you looking for resources, click on the resource type to explore further.

1-3 of 3 Resources
Flyer Icon
Flyer
No-wash cytokine assay solutions

Cytokines play a vital role in both innate and adaptive immunity and are known for their ability to exert diverse functions on...

Flyer Icon
Flyer
Reagent solutions for autoimmunity research.

Advance your autoimmune disease research and benefit from Revvity broad offering of reagent technologies

Flyer Icon
Flyer
Solutions to advance your CART-T cell research

Chimeric antigen receptor (CAR) T-cell therapy has transformed the field of immuno-oncology providing a novel approach to treating...

Scroll Icon